Works matching IS 19466234 AND DT 2011 AND VI 3 AND IP 95

Results: 7
    1
    2
    3

    Curaxins: Anticancer Compounds that Simultaneously Suppress NF-kB and Activate p53 by Targeting FACT.

    Published in:
    Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002530
    By:
    • Gasparian, Alexander V.;
    • Burkhart, Catherine A.;
    • Purmal, Andrei A.;
    • Brodsky, Leonid;
    • Pal, Mahadeb;
    • Saranadasa, Madhi;
    • Bosykh, Dmitry A.;
    • Commane, Mairead;
    • Guryanova, Olga A.;
    • Pal, Srabani;
    • Safina, Alfiya;
    • Sviridov, Sergey;
    • Koman, Igor E.;
    • Veith, Jean;
    • Komar, Anton A.;
    • Gudkov, Andrei V.;
    • Gurova, Katerina V.
    Publication type:
    Article
    4
    5

    Rare Copy Number Variation Discovery and Cross- Disorder Comparisons Identify Risk Genes for ADHD.

    Published in:
    Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002464
    By:
    • Lionel, Anath C.;
    • Crosbie, Jennifer;
    • Barbosa, Nicole;
    • Goodale, Tara;
    • Thiruvahindrapuram, Bhooma;
    • Rickaby, Jessica;
    • Gazzellone, Matthew;
    • Carson, Andrew R.;
    • Howe, Jennifer L.;
    • Zhuozhi Wang;
    • John Wei;
    • Stewart, Alexandre F. R.;
    • Roberts, Robert;
    • McPherson, Ruth;
    • Fiebig, Andreas;
    • Franke, Andre;
    • Schreiber, Stefan;
    • Zwaigenbaum, Lonnie;
    • Fernandez, Bridget A.;
    • Roberts, Wendy
    Publication type:
    Article
    6
    7

    Cancer Drug Discovery Faces the FACT.

    Published in:
    Science Translational Medicine, 2011, v. 3, n. 95, p. 1, doi. 10.1126/scitranslmed.3002822
    By:
    • Draetta, Giulio F.;
    • DePinho, Ronald A.
    Publication type:
    Article